On this episode, hosts Scott and Sarah sit down with Shaemus Gleason, Executive Vice President at Clarity Pharmaceuticals.

The discussion highlights Shaemus's journey through the radiopharmaceutical industry, Clarity's innovations, and breakthroughs involving copper-based compounds for cancer treatment. 

Shaemus shares insights on the importance of chelators, supply chain logistics, and diagnostic imaging, emphasizing the need for universal patient access and the evolution of personalized medicine. The episode concludes with an optimistic outlook on the industry's future and things to look out for in the future.

—-----

Time Stamps:

• *(01:18) Building a Career in Radiopharma
• *(05:54) Racing against the half-life
• *(09:17) Clarity and Chelation
• *(14:52) Theranostic Parings
• *(20:19) Picking Winners: The Pathway to Commercial Development
• *(27:19) What Makes A "Good Responder"?
• *(30:36) Making it Easy for the Patient
• *(39:01) The Renaissance of Radiopharma

--------

‘Talk Radioisotopes: Going Nuclear on Cancer’ is brought to you by Nusano, a physics company whose breakthrough technologies are poised to help supply the fight against cancer and enable innovation across multiple industries. Find out more at Nusano.com.

--------

Links:

Follow Shaemus on LinkedIn

Visit Clarity Pharmaceuticals

Talkradioisotopes.com

—----